Akso Health Group Files 6-K on Direct Offering
Ticker: AHG · Form: 6-K · Filed: Mar 8, 2024 · CIK: 1702318
| Field | Detail |
|---|---|
| Company | Akso Health Group (AHG) |
| Form Type | 6-K |
| Filed Date | Mar 8, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $49.34 million, $0.4933, $1.48, $1.33 |
| Sentiment | neutral |
Sentiment: neutral
Topics: offering, corporate-action, foreign-issuer
TL;DR
Akso Health Group filed a 6-K on March 8th detailing a March 5th direct offering.
AI Summary
Akso Health Group filed a Form 6-K on March 8, 2024, reporting on a registered direct offering that occurred on March 5, 2024. The filing provides details about the company's principal executive offices located in Qingdao Pilot Free Trade Zone, China, and its previous names, Xiaobai Maimai Inc. and Hexindai Inc.
Why It Matters
This filing indicates recent corporate activity, specifically a direct offering, which could impact the company's capital structure and shareholder value.
Risk Assessment
Risk Level: medium — Form 6-K filings often contain updates on corporate actions like offerings, which can introduce volatility and require investors to assess potential dilution or capital changes.
Key Players & Entities
- Akso Health Group (company) — Registrant
- March 8, 2024 (date) — Filing Date
- March 5, 2024 (date) — Registered Direct Offering Date
- Qingdao Pilot Free Trade Zone, China (location) — Principal Executive Offices
- Xiaobai Maimai Inc. (company) — Former Company Name
- Hexindai Inc. (company) — Former Company Name
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that the company has made or is required to make public pursuant to the laws of its home country or that it has filed or will file with a stock exchange.
When did Akso Health Group conduct its registered direct offering?
Akso Health Group conducted its registered direct offering on March 5, 2024.
Where are Akso Health Group's principal executive offices located?
Akso Health Group's principal executive offices are located at Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building, No. 44, Moscow Road, Qianwan Bonded Port Area, Qingdao Pilot Free Trade Zone, China.
What were Akso Health Group's previous company names?
Akso Health Group was formerly known as Xiaobai Maimai Inc. and Hexindai Inc.
What is the filing date of this Form 6-K?
This Form 6-K was filed on March 8, 2024.
Filing Stats: 542 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-03-08 16:05:06
Key Financial Figures
- $0.0001 — 111,300,000 ordinary shares, par value $0.0001 per share (“ Ordinary Shares &rdq
- $49.34 million — ent for gross proceeds of approximately $49.34 million (the “ Offering ”). The wa
- $0.4933 — ate of issuance at an exercise price of $0.4933 per ordinary share, or $1.48 per ADS an
- $1.48 — price of $0.4933 per ordinary share, or $1.48 per ADS and expire five years from the
- $1.33 — h ADS and the corresponding Warrants is $1.33. Each Warrant is subject to anti-diluti
Filing Documents
- ea0201437-6k_aksohealth.htm (6-K) — 14KB
- ea020143701ex5-1_aksohealth.htm (EX-5.1) — 44KB
- ea020143701ex99-1_aksohealth.htm (EX-99.1) — 115KB
- ea020143701ex99-2_aksohealth.htm (EX-99.2) — 72KB
- ex5-1_001.jpg (GRAPHIC) — 8KB
- ex5-1_002.jpg (GRAPHIC) — 40KB
- ex5-1_003.jpg (GRAPHIC) — 27KB
- 0001213900-24-021044.txt ( ) — 351KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Akso Health Group By: /s/ Yilin (Linda) Wang Name: Yilin (Linda) Wang Title: Chief Executive Officer Date: March 8, 2024 2